Lan Chen

Lan Chen

Auto-generated profile, based on publicly available information

Lan Chen

Merck & Co., Inc., Kenilworth, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
PLPengfei Li
Pengfei Li
LCLan Chen
Lan Chen
YNYan Ni
Yan Ni
JLJiaqi Liu
Jiaqi Liu
DLDonglin Li
Donglin Li
CCChunlin Chen
Chunlin Chen
Li P, et al. J Gynecol Oncol. 2020 Oct;32:e17. https://doi.org/10.3802/jgo.2021.32.e17

22 March 2021 in Infectious Diseases and Therapy
Verified
Journal Article
Open access
PDF file
HZHailong Zhao
Hailong Zhao
DNDavid C. Nickle
David C. Nickle
ZZZhen Zeng
Zhen Zeng
PLPierra Y. T. Law
Pierra Y. T. Law
MWMark H. Wilcox
Mark H. Wilcox
JLJunhua LI
Junhua LI
Introduction Clostridioides (Clostridium) difficile infection, the leading cause of healthcare-associated diarrhea, represents a significant burden on global healthcare systems. Despite being a global issue, information on C. difficile from a global perspective is lacking. The aim of this study is to model the global phylogeography of clinical C. difficile. Methods Using samples collected from the MODIFY I and II studies (NCT01241552, NCT01513239), we performed whole-genome sequencing of 1501 clinical isolates including 37 novel sequence types (STs), representing the largest worldwide collection to date. Results Our data showed ribotypes, multi-locus sequence typing clades, and whole-genome phylogeny were in good accordance. The clinical C. difficile genome was found to be more conserved than previously reported (61% core genes), and modest recombination rates of 1.4–5.0 were observed across clades. We observed a significant continent distribution preference among five C. difficile clades (Benjamini-Hochberg corrected Fisher’s exact test P < 0.01); moreover, weak association between geographic and genetic distance among ribotypes suggested sources beyond healthcare-related transmission. Markedly different trends of antibiotic susceptibility among lineages and regions were identified, and three novel mutations (in pyridoxamine 5′-phosphate oxidase family protein: Tyr130Ser, Tyr130Cys, and a promoter SNP) associated with metronidazole-reduced susceptibility were discovered on a nim-related gene and its promotor by genome-wide association study. Toxin gene polymorphisms were shown to vary within and between prevalent ribotypes, and novel severe mutations were found on the tcdC toxin regulator protein. Conclusion Our systematic characterization of a global set of clinical trial C. difficile isolates from infected individuals demonstrated the complexity of the genetic makeup of this pathogenic organism. The geographic variability of clades, variability in toxin genes, and mutations associated with antibiotic susceptibility indicate a highly complex interaction of C. difficile between host and environment. This dataset will provide a useful resource for validation of findings and future research of C. difficile.

1 January 2019 in European Journal of Radiology
Verified
Journal Article
Closed access
KLKedan Liao
Kedan Liao
LTLian Tang
Lian Tang
CPCheng Peng
Cheng Peng
LCLan Chen
Lan Chen
RCRuiying Chen
Ruiying Chen
CCChunlin Chen
Chunlin Chen